The 30 compounds with selective toxicity for PER-485 cells were then further screened for inhibitory action against a panel of 14 additional cell lines, comprising an additional MLL-AF4, a MLL-AF9 and six MLL-wt leukemia lines, three solid tumour cell lines and three types of normal cells. Here, KMT2A is linked to leukemia.